Three kidneys, two diseases, one antibody?

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3811-3813

  Lorcy, Nolwenn ^a   Rioux Leclercq, Nathalie ^a   Lombard, Marie Laure ^b   Le Pogamp, Patrick ^a   Vigneau, Cécile ^a,c  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Service de Néphrologie   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

anti factor H antibody; complement alternative pathway; membranoproliferative glomerulonephritis; thombotic microangiopathies

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BASILIXIMAB; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H ANTIBODY; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G; IRBESARTAN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROPATHY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; COMPLEMENT C3; COMPLEMENT FACTOR H; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GRAFT REJECTION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; PROGNOSIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 80155136247     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr436     Document Type: Article

References (8)

1. Dragon-Durey M, Loirat C, Cloarec S et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16: 555-563
2. Dragon-Durey M, Sethi SK, Bagga A et al. Clinical features of antifactor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol 2010; 21: 2180-2187
3. Meri S, Koistinen V, Miettinen A et al. Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med 1992; 175: 939-950
4. Boyer O, Noël L, Balzamo E et al. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits. Am J Kidney Dis 2008; 51: 671-677
5. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-1687
6. Skerka C, Licht C, Mengel M et al. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles. Mol Immunol 2009; 46: 2801-2807
7. Kwon T, Dragon-Durey M, Macher M et al. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol Dial Transplant 2008; 23: 2088-2090
8. de Jorge EG, Macor P, Paixão-Cavalcante D et al. The development of atypical hemolytic uremic syndrome depends on complement C5. J Am Soc Nephrol 2011; 22: 137-145